Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation

摘要: Percutaneous coronary intervention (PCI) has traditionally not been an option for patients with end-stage liver disease (ESLD) and artery (CAD). This retrospective study was designed to demonstrate the feasibility safety of PCI in transplant candidates. Patients ESLD hemodynamically significant CAD who were otherwise deemed be acceptable candidates transplantation underwent PCI. The procedural success rates, mortality myocardial infarction bleeding outcomes examined. Sixteen PCI: 15 bare-metal stents (1.3 per patient on average) 1 balloon angioplasty alone. median diameter stenosis lesion 80%, platelet count 68 × 10(9) /L, international normalized ratio 1.3, Model End-Stage Liver Disease score 13. successful 94% patients. One had a suboptimal residual 50% after stenting. There no in-hospital or 30-day deaths infarctions, developed hematomas. required 1-U transfusion, another U packed red blood cells. All remained clinically stable month Nine 16 listed transplantation, 3 transplantation. In conclusion, we have demonstrated small cohort CAD, majority whom thrombocytopenia. Larger studies are determine whether is effective treatment strategy would